Effects of eplerenon in chronik kidney disease with hypertensio
Phase 4
- Conditions
- chronick kidney disease with hypertension
- Registration Number
- JPRN-UMIN000010789
- Lead Sponsor
- Division of Nephrology, Department of Internal medicine, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)diabetes mellitus with microalbuminuria or proteinuria 2)patinets who have allegry for eplerenon 3)hyperkalemia (> 5.5 mEq/ml) 4)chronic kidney disease patients whose eGFR is under 50ml/min/1.73m2 5)severe liver dysfunction 6)patinets who are taking potassiums or potassium-sparing diuretics 7)pregnant women 8)patinets who are taking itraconazole, ritonavir or nelfinavir 9)patinets who will not give informed concent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of blood pressure, heart function, renal function
- Secondary Outcome Measures
Name Time Method